BB&T Capital Cuts Chattem to Hold from Buy

Cites uncertainty about the outlook for the healthcare products maker's business

BB&T Capital downgraded Chattem (CHTT) to hold from buy, citing uncertainty about the outlook for the healthcare products maker's business.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.